J. Siegel

发表

Sudden death following intravenous sodium diphenylhydantoin.

S. Zoneraich, O. Zoneraich, J. Siegel, 1976, American heart journal.

The effect of a legislative mandate on preferences and practices for colon cancer screening in average risk patients over age 50

J. Siegel, 2001 .

A Prospective, Multi-Center Clinical Utility Study Demonstrates That the 40-Gene Expression Profile (40-GEP) Test Impacts Clinical Management for Medicare-Eligible Patients with High-Risk Cutaneous Squamous Cell Carcinoma (cSCC)

S. Ibrahim, J. Siegel, A. Fitzgerald, 2022, SKIN The Journal of Cutaneous Medicine.

Uveal melanoma patient attitudes towards prognostic testing using gene expression profiling

P. Hovland, Katherina M. Alsina, Basil K. Williams, 2022, Melanoma management.

Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients

A. Prasai, Graham H Litchman, J. Siegel, 2022, Cancer investigation.

Attitudes of patients with cutaneous melanoma toward prognostic testing using the 31‐gene expression profile test

J. Siegel, K. Ahmed, Kyleigh LiPira, 2022, Cancer medicine.

31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.

M. Schymura, K. Covington, R. Cress, 2023, JCO precision oncology.

A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's Esophagus

J. Goldblum, J. Bergman, G. Falk, 2023, Clinical and Translational Gastroenterology.

An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus

R. Pouw, J. Bergman, R. Critchley-Thorne, 2023, American Journal of Gastroenterology.